Seretide 50mcg/500mcg Accuhaler is a prescription inhaler that combines Salmeterol, a long-acting bronchodilator, and Fluticasone Propionate, a corticosteroid. It is widely used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). By opening the airways and reducing inflammation, it helps improve breathing and prevents flare-ups. For more insights, you can explore trusted health resources such as Mayo Clinic, Drugs.com, and WebMD.

Key Benefits & Uses

• Asthma Management: Prevents wheezing, chest tightness, and shortness of breath.

• COPD Relief: Relaxes airway muscles and improves airflow, helping you breathe with ease.

• Long-lasting Effect: Provides sustained relief, improving overall quality of life.

• Trigger Prevention: Reduces the risk of asthma attacks caused by allergens, exercise, or smoke.

Clinical evidence supporting its efficacy can be found in PubMed and official guidelines at the World Health Organization (WHO).

How to Use

Take Seretide Accuhaler exactly as prescribed by your doctor. Inhale the dose regularly, even if you feel well, to ensure maximum effectiveness. It should not be used as a rescue inhaler for sudden asthma attacks. For proper inhalation techniques and patient guidance, see MedlinePlus and FDA.

Important Safety Information

• Not suitable for sudden asthma attacks; always keep a quick-relief inhaler handy.

• Inform your doctor if you are pregnant, breastfeeding, or have liver/kidney conditions.

• Avoid smoking and triggers that worsen asthma or COPD.

• Learn more from Healthline and WHO.

Common Side Effects

Most side effects are mild and temporary. They may include:

• Cough, headache, hoarseness, sore throat

• Fungal infection in the mouth (thrush)

• Upper respiratory tract infection, sinus irritation

• Muscle or joint pain

• Dry mouth

If persistent or severe, consult your doctor. Helpful resources: WebMD and Drugs.com.

Why Choose Seretide Accuhaler?

• Trusted combination of Salmeterol and Fluticasone.

• Clinically proven to manage asthma and COPD effectively.

• Provides long-term control and improves quality of life.

• Recommended by global health authorities such as WHO and supported by clinical data from PubMed.